Back
AbbVie, Inc. Vs. Novanta, Inc. Industry Stock Comparison
Buy
62
ABBV
AbbVie, Inc.
Last Price:
$231.54
Seasonality Move:
2.16%
Sell
46
NOVT
Novanta, Inc.
Last Price:
$122.83
Seasonality Move:
13.22%
Buy
62
AbbVie, Inc. (ABBV)
is a Buy
Is AbbVie, Inc. a Buy, Sell or Hold?
-
The current AbbVie, Inc. [ABBV] share price is $233.42. The Score for ABBV is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
ABBV is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Novanta, Inc. (NOVT)
is a Sell
Is Novanta, Inc. a Buy, Sell or Hold?
-
The current Novanta, Inc. [NOVT] share price is $124.28. The Score for NOVT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
NOVT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ABBV Stock Price Chart
What is AbbVie, Inc.'s stock price today?
-
The AbbVie, Inc. share price today is $233.42Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ABBV is experiencing slight buying pressure.
NOVT Stock Price Chart
What is Novanta, Inc.'s stock price today?
-
The Novanta, Inc. share price today is $124.28Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NOVT is experiencing slight buying pressure.
ABBV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.37 | Buy |
| Relative Strength Index (14 RSI): | 58.16 | Buy |
| Chaikin Money Flow: | 4231223 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (223.4 - 229.84) | Buy |
| Bollinger Bands (100): | (215.21 - 231.89) | Buy |
NOVT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.86 | Buy |
| Relative Strength Index (14 RSI): | 58.98 | Buy |
| Chaikin Money Flow: | 120692 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (115.33 - 122.67) | Buy |
| Bollinger Bands (100): | (105.67 - 122.43) | Buy |
ABBV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 228.24 | Buy |
| 20-day SMA: | 226.65 | Buy |
| 50-day SMA: | 226.51 | Buy |
| 200-day SMA: | 206.35 | Buy |
| 8-day EMA: | 227.83 | Buy |
| 20-day EMA: | 227.4 | Buy |
| 50-day EMA: | 226.15 | Buy |
| 200-day EMA: | 211.25 | Buy |
NOVT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 121.04 | Buy |
| 20-day SMA: | 120.16 | Buy |
| 50-day SMA: | 116.87 | Buy |
| 200-day SMA: | 118.73 | Buy |
| 8-day EMA: | 121.01 | Buy |
| 20-day EMA: | 119.46 | Buy |
| 50-day EMA: | 116.82 | Buy |
| 200-day EMA: | 122.55 | Buy |
AbbVie, Inc. Earnings Growth & ABBV Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.62 per share, and an increase next year of $1.59 per share.
Novanta, Inc. Earnings Growth & NOVT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $0.45 per share.
AbbVie, Inc. Technical Analysis
| Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 23 | 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novanta, Inc. Technical Analysis
| Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 22 | 23 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||